VIM and asthma: In asthma, during airway smooth muscle (ASM) remodeling, IL-17, through the ZEB1 pathway, reduces the expression of E-cadherin and increases the expression of vimentin, promoting the thickening of the ASM layer driven by Th17 cells in severe asthma [31].